stockportfolio.pro
Akso Health Group (AHG)
Healthcare · Medical Distribution · NasdaqCM
Akso Health Group revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $6.00M | $13.18M | $2.41M | $14.78M |
| Gross profit | $605,134 | $1.27M | $122,132 | $-281,526 |
| Net income | $-16.85M | $-1.36M | $-9.46M | $-134.98M |
| Net margin | -280.9% | -10.3% | -391.8% | -913.4% |
Source: Akso Health Group SEC filings (10-K).
What growth is priced into AHG stock?
At today's market cap of $1.24B, Akso Health Group is priced for free-cash-flow growth of about 69.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.02M from the FY ending 2025-03-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Akso Health Group financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track AHG in your portfolio →
Akso Health Group financial history by metric
About Akso Health Group
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Akso Health Group — frequently asked questions
What is Akso Health Group's revenue?
Akso Health Group (AHG) reported revenue of $14.78M for fiscal year 2025, up 512.1% from the prior year, according to its SEC filings.
Is Akso Health Group profitable?
No — AHG reported a net loss of $-134.98M in fiscal 2025.
What is AHG's P/E ratio?
Akso Health Group trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Akso Health Group growing?
AHG's revenue grew at roughly 35.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Akso Health Group have?
As of fiscal year 2025, AHG carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Akso Health Group's gross margin?
AHG's gross margin was -1.9% in fiscal 2025 — gross profit of $-281,526 on revenue of $14.78M.
What is Akso Health Group's market cap?
Akso Health Group (AHG) has a market capitalization of about $1.24B, based on the latest data in our nightly-refreshed cache.
When does Akso Health Group's fiscal year end?
AHG's fiscal year ends in March. Its most recent annual filing covers the fiscal year ending 2025-03-31.
What growth is priced into AHG stock?
At today's market cap of $1.24B, Akso Health Group is priced for free-cash-flow growth of about 69.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.02M from the FY ending 2025-03-31).
Where does this data come from?
All figures are computed from Akso Health Group's official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.